title: The Emervel French survey: a prospective real-practice descriptive study of 1,822 patients treated for facial rejuvenation with a new hyaluronic acid filler.
abstract: BACKGROUND
  Emervel consists of a range of 5 hyaluronic acid (HA) fillers (Touch, Classic, Lips, Deep, and Volume), with a fixed HA concentration (20 mg/mL), and various degrees of cross-linking and calibration.
  
  
  OBJECTIVE
  To describe the current use of Emervel fillers in France.
  
  
  METHODS
  Prospective multicenter, cross-sectional, real-practice, descriptive survey, including 1,822 patients injected with Emervel fillers for face rejuvenation by 58 French physicians between September 2010 and July 2011. The injection modalities were left to the respective physician's discretion.
  
  
  RESULTS
  The physicians were dermatologists (52.3%), surgeons (43.8%), or general practitioners (14.1%). Nasolabial folds (NLF) with a mean severity 2.4 were mainly injected with Emervel Deep (51.0%) and Emervel Classic (36.0%) (mean volume: 1.0 mL), and primarily with the linear retrograde (LR) technique (89.3%). Marionette lines (ML), with a mean severity 2.6 were mainly injected with Emervel Deep (52.5%) and Emervel Classic (34.6%) (mean volume: 0.8 mL), and mainly with the LR technique (79.5%). More than 90% of patients had scores of 0 or 1 for erythema, bruising, edema, and pain. No serious adverse events were reported up to 15 months after the injection.
  
  
  CONCLUSIONS
  These data could contribute to upcoming international consensus on optimal injection modalities of the Emervel range of HA fillers.
authors: Dermatology Clinic, 75013 Paris, France. farhidavid@yahoo.fr
authors: David
authors: D
authors: Farhi
authors: Patrick
authors: P
authors: Trevidic
authors: Philippe
authors: P
authors: Kestemont
authors: Dominique
authors: D
authors: Boineau
authors: Hugues
authors: H
authors: Cartier
authors: Isaac
authors: I
authors: Bodokh
authors: Patrick
authors: P
authors: Brun
authors: Benjamin
authors: B
authors: Ascher
authors: Jacques
authors: J
authors: Savary
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003357:Cosmetic Techniques; D003432:Cross-Linking Reagents / Q000737:chemistry; D003430:Cross-Sectional Studies; D005145:Face; D005260:Female; D005602:France; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D007267:Injections; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012060:Rejuvenation; D015595:Skin Aging; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D003432:Cross-Linking Reagents; D006820:Hyaluronic Acid